Published in Cancer Weekly, May 10th, 2005
The purpose of the study conducted by A. Du Bois and colleagues, Dr. Horst Schmidt Clinic, Wiesbaden, "was to evaluate the pattern and quality of care for ovarian cancer in Germany and analyze prognostic factors with emphasis on characteristics of treating institutions, hospital volume, and participation in clinical trials."
Data came from a "national survey including patients with histologically proven...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.